Amphastar Pharmaceuticals Inc
General ticker "AMPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.1B
Amphastar Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -9.5%.
Estimated limits based on current volatility of 2.3%: low 38.39$, high 40.20$
Factors to consider:
- US accounted for 98.6% of revenue in the fiscal year ended 2023-12-31
- Current price 16.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [46.64$, 69.46$]
- 2024-12-30 to 2025-12-30 estimated range: [52.98$, 77.91$]
Financial Metrics affecting the AMPH estimates:
- Positive: Non-GAAP EPS, $ of 3.30 > 2.29
- Positive: Operating profit margin, % of 30.57 > 19.51
- Positive: Interest expense per share, $ of 0.56 <= 0.74
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term AMPH quotes
Long-term AMPH plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $437.77MM | $498.99MM | $644.39MM |
Operating Expenses | $367.88MM | $391.49MM | $447.41MM |
Operating Income | $69.89MM | $107.50MM | $196.99MM |
Non-Operating Income | $14.25MM | $8.54MM | $-25.63MM |
Interest Expense | $0.89MM | $1.85MM | $27.16MM |
R&D Expense | $60.93MM | $74.77MM | $73.74MM |
Income(Loss) | $84.14MM | $116.04MM | $171.36MM |
Taxes | $20.63MM | $23.48MM | $31.83MM |
Other Income(Loss) | $-0.21MM | $-1.18MM | $-1.98MM |
Profit(Loss) | $63.30MM | $91.39MM | $137.54MM |
Stockholders Equity | $445.52MM | $528.66MM | $639.42MM |
Inventory | $92.81MM | $103.58MM | $105.83MM |
Assets | $671.53MM | $741.99MM | $1,512.91MM |
Operating Cash Flow | $97.99MM | $89.18MM | $183.50MM |
Capital expenditure | $27.46MM | $24.03MM | $38.17MM |
Investing Cash Flow | $-28.67MM | $-32.78MM | $-649.12MM |
Financing Cash Flow | $-37.02MM | $-26.44MM | $454.09MM |
Earnings Per Share* | $1.30 | $1.88 | $2.85 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.